Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia Galvan

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Biorxiv : the Preprint Server for Biology|May 7, 2026
mGluR6 coordinates cone terminal targeting and synaptic layer assembly during human retinal developmentLeila Bahmani, Patricia Galvan, Hirad Hosseini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Incidence of Norovirus-Associated Diarrhea and Vomiting Disease Among Children and Adults in a Community Cohort in the Peruvian Amazon BasinCandice Romero, Yeny O Tinoco, Sebastian Loli, et al.
Revista Peruana De Medicina Experimental Y Salud Publica|June 21, 2018
[Connection Between Genetic Polymorphism of Interleukin -1Beta With Chronic Periodontitis in Peruvian Adults]Ivonne F Reyes-Mandujano, José E Olivera-García, Manuel Taboada-Vega, et al.
Scientific Reports|October 9, 2024
Neoadjuvant sunitinib plus exemestane in post-menopausal women with hormone receptor-positive/HER2-negative early-stage breast cancer (SUT_EXE-08): a phase I/II trialBartomeu Fullana, Serafín Morales, Anna Petit, et al.
NPJ Breast Cancer|November 26, 2024
Palbociclib and letrozole for hormone receptor-positive HER2-negative breast cancer with residual disease after neoadjuvant chemotherapySonia Pernas, Esther Sanfeliu, Guillermo Villacampa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2012
A three-gene expression signature model for risk stratification of patients with neuroblastomaIdoia Garcia, Gemma Mayol, José Ríos, et al.
Journal of Virology|February 28, 2006
Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus controlRosario Zuñiga, Aldo Lucchetti, Patricia Galvan, et al.
Frontiers in Pharmacology|February 4, 2021
Multispecies Evaluation of a Long-Acting Tenofovir Alafenamide Subdermal Implant for HIV ProphylaxisManjula Gunawardana, Mariana Remedios-Chan, Debbie Sanchez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2021
Independent Validation of the PAM50-Based Chemo-Endocrine Score (CES) in Hormone Receptor-Positive HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2-Based TherapyTomás Pascual, Aranzazu Fernandez-Martinez, Maki Tanioka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2025
Palbociclib, trastuzumab and endocrine therapy in pretreated HER2-positive and PAM50 luminal advanced breast cancer: randomised phase II, SOLTI-1303 PATRICIA trialEva Ciruelos, Tomás Pascual, Guillermo Villacampa, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Biorxiv : the Preprint Server for Biology|May 7, 2026
mGluR6 coordinates cone terminal targeting and synaptic layer assembly during human retinal developmentLeila Bahmani, Patricia Galvan, Hirad Hosseini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Incidence of Norovirus-Associated Diarrhea and Vomiting Disease Among Children and Adults in a Community Cohort in the Peruvian Amazon BasinCandice Romero, Yeny O Tinoco, Sebastian Loli, et al.
Revista Peruana De Medicina Experimental Y Salud Publica|June 21, 2018
[Connection Between Genetic Polymorphism of Interleukin -1Beta With Chronic Periodontitis in Peruvian Adults]Ivonne F Reyes-Mandujano, José E Olivera-García, Manuel Taboada-Vega, et al.
Scientific Reports|October 9, 2024
Neoadjuvant sunitinib plus exemestane in post-menopausal women with hormone receptor-positive/HER2-negative early-stage breast cancer (SUT_EXE-08): a phase I/II trialBartomeu Fullana, Serafín Morales, Anna Petit, et al.
NPJ Breast Cancer|November 26, 2024
Palbociclib and letrozole for hormone receptor-positive HER2-negative breast cancer with residual disease after neoadjuvant chemotherapySonia Pernas, Esther Sanfeliu, Guillermo Villacampa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2012
A three-gene expression signature model for risk stratification of patients with neuroblastomaIdoia Garcia, Gemma Mayol, José Ríos, et al.
Journal of Virology|February 28, 2006
Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus controlRosario Zuñiga, Aldo Lucchetti, Patricia Galvan, et al.
Frontiers in Pharmacology|February 4, 2021
Multispecies Evaluation of a Long-Acting Tenofovir Alafenamide Subdermal Implant for HIV ProphylaxisManjula Gunawardana, Mariana Remedios-Chan, Debbie Sanchez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2021
Independent Validation of the PAM50-Based Chemo-Endocrine Score (CES) in Hormone Receptor-Positive HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2-Based TherapyTomás Pascual, Aranzazu Fernandez-Martinez, Maki Tanioka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2025
Palbociclib, trastuzumab and endocrine therapy in pretreated HER2-positive and PAM50 luminal advanced breast cancer: randomised phase II, SOLTI-1303 PATRICIA trialEva Ciruelos, Tomás Pascual, Guillermo Villacampa, et al.
Pageof 2